These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 27324762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
    Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP.
    J Infect Dis; 2011 Aug 01; 204(3):340-7. PubMed ID: 21742831
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Oct 01; 60(10):5841-8. PubMed ID: 27431221
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting.
    Adani S, Bhowmick T, Weinstein MP, Narayanan N.
    Antimicrob Agents Chemother; 2018 Apr 01; 62(4):. PubMed ID: 29378704
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M, Rossel A, de Kraker MEA, von Dach E, Marti C, Emonet S, Harbarth S, Kaiser L, Uçkay I.
    Clin Microbiol Infect; 2020 May 01; 26(5):626-631. PubMed ID: 31357013
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
    López-Cortés LE, Velasco C, Retamar P, del Toro MD, Gálvez-Acebal J, de Cueto M, García-Luque I, Caballero FJ, Pascual A, Rodríguez-Baño J.
    J Antimicrob Chemother; 2015 Sep 01; 70(9):2652-60. PubMed ID: 26023210
    [Abstract] [Full Text] [Related]

  • 11. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.
    Int J Antimicrob Agents; 2012 Aug 01; 40(2):108-13. PubMed ID: 22633565
    [Abstract] [Full Text] [Related]

  • 12. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
    Honda H, Doern CD, Michael-Dunne W, Warren DK.
    BMC Infect Dis; 2011 Dec 05; 11():335. PubMed ID: 22142287
    [Abstract] [Full Text] [Related]

  • 13. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2008 Jan 05; 52(1):192-7. PubMed ID: 17984229
    [Abstract] [Full Text] [Related]

  • 14. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
    Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250
    [Abstract] [Full Text] [Related]

  • 15. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
    Mylotte JM, Tayara A.
    Clin Infect Dis; 2000 Nov 15; 31(5):1170-4. PubMed ID: 11073748
    [Abstract] [Full Text] [Related]

  • 16. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.
    Clin Infect Dis; 2013 Jun 15; 56(11):1562-9. PubMed ID: 23449272
    [Abstract] [Full Text] [Related]

  • 17. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H, Maeda M, Shirakura T, Takuma T, Ugajin K, Fukuchi K, Ishino K, Niki Y.
    Int J Antimicrob Agents; 2015 Nov 15; 46(5):532-7. PubMed ID: 26364848
    [Abstract] [Full Text] [Related]

  • 18. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
    de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD.
    Diagn Mol Pathol; 2011 Sep 15; 20(3):184-8. PubMed ID: 21817905
    [Abstract] [Full Text] [Related]

  • 19. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP.
    Pharmacotherapy; 2015 Oct 15; 35(10):889-98. PubMed ID: 26497475
    [Abstract] [Full Text] [Related]

  • 20. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
    Rosa R, Wawrzyniak A, Sfeir M, Smith L, Abbo LM.
    J Hosp Med; 2016 Jan 15; 11(1):27-32. PubMed ID: 26381394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.